Solana Company CMO Antonella Favit-Van Pelt departs with $875,000 separation payment

Solana Co

Dr. Favit-Van Pelt resigned as Chief Medical Officer effective April 8, 2026, under a mutual separation agreement.
Separation payment of $875,000 lump sum within 10 business days; retains 18,037 vested stock options.
No successor named; confidentiality, non-disparagement, and cooperation obligations continue.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Antonella Favit-Van Pelt

Chief Medical Officer

Solana Co

Effective: 2026-04-08
Filed: Apr 13, 2026 23:59 UTC

On April 8, 2026, Solana Company (the “Company”) and Antonella Favit-Van Pelt, MD, PhD, mutually agreed that Dr. Favit-Van Pelt would separate from the Company and resign as the Company’s Chief Medical Officer, effective as of April 8, 2026

Source: SEC EDGAR

accession 0001104659-26-042666

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.